全部 标题 作者 关键词 摘要
DOI: 10.5306/wjco.v10.i7.247
Keywords: Case report, Nivolumab, Clinical oncology, Checkpoint inhibition, Gynecologic oncology, Pseudoprogression, Immunooncology
Full-Text Cite this paper Add to My Lib
Full-Text
Contact Us
service@oalib.com
QQ:3279437679
WhatsApp +8615387084133